46. An AHR treatment provider shall not provide PGT-A except for the purposes of genetically testing an embryo for a chromosomal variant that may affect the capacity of the embryo to result in a live birth where—
(a) PGT-M or PGT-SR is being undertaken, or
(b) such testing has been indicated in accordance with criteria that have been prescribed (following, on and after the establishment day, consultation by the Minister with the AHRRA).
